Literature DB >> 27039975

Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice.

Katharina Jähn1, Hiroaki Saito2, Hanna Taipaleenmäki2, Andreas Gasser2, Norbert Hort3, Frank Feyerabend3, Hartmut Schlüter4, Johannes M Rueger5, Wolfgang Lehmann5, Regine Willumeit-Römer3, Eric Hesse6.   

Abstract

UNLABELLED: Intramedullary stabilization is frequently used to treat long bone fractures. Implants usually remain unless complications arise. Since implant removal can become technically very challenging with the potential to cause further tissue damage, biodegradable materials are emerging as alternative options. Magnesium (Mg)-based biodegradable implants have a controllable degradation rate and good tissue compatibility, which makes them attractive for musculoskeletal research. Here we report for the first time the implantation of intramedullary nails made of an Mg alloy containing 2% silver (Mg2Ag) into intact and fractured femora of mice. Prior in vitro analyses revealed an inhibitory effect of Mg2Ag degradation products on osteoclast differentiation and function with no impair of osteoblast function. In vivo, Mg2Ag implants degraded under non-fracture and fracture conditions within 210days and 133days, respectively. During fracture repair, osteoblast function and subsequent bone formation were enhanced, while osteoclast activity and bone resorption were decreased, leading to an augmented callus formation. We observed a widening of the femoral shaft under steady state and regenerating conditions, which was at least in part due to an uncoupled bone remodeling. However, Mg2Ag implants did not cause any systemic adverse effects. These data suggest that Mg2Ag implants might be promising for intramedullary fixation of long bone fractures, a novel concept that has to be further investigated in future studies. STATEMENT OF SIGNIFICANCE: Biodegradable implants are promising alternatives to standard steel or titanium implants to avoid implant removal after fracture healing. We therefore developed an intramedullary nail using a novel biodegradable magnesium-silver-alloy (Mg2Ag) and investigated the in vitro and in vivo effects of the implants on bone remodeling under steady state and fracture healing conditions in mice. Our results demonstrate that intramedullary Mg2Ag nails degrade in vivo over time without causing adverse effects. Importantly, radiographs, μCT and bone histomorphometry revealed a significant increase in callus size due to an augmented bone formation rate and a reduced bone resorption in fractures supported by Mg2Ag nails, thereby improving bone healing. Thus, intramedullary Mg2Ag nails are promising biomaterials for fracture healing to circumvent implant removal.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biodegradation; Bone healing; Callus formation; Intramedullary fracture fixation; Mg2Ag alloy

Mesh:

Substances:

Year:  2016        PMID: 27039975     DOI: 10.1016/j.actbio.2016.03.041

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  13 in total

Review 1.  Mg-, Zn-, and Fe-Based Alloys With Antibacterial Properties as Orthopedic Implant Materials.

Authors:  Ning Wang; Yutong Ma; Huixin Shi; Yiping Song; Shu Guo; Shude Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-23

Review 2.  Update on the research and development of magnesium-based biodegradable implants and their clinical translation in orthopaedics.

Authors:  Ying Luo; Jue Wang; Michael Tim Yun Ong; Patrick Shu-Hang Yung; Jiali Wang; Ling Qin
Journal:  Biomater Transl       Date:  2021-09-28

Review 3.  Magnesium-based materials in orthopaedics: material properties and animal models.

Authors:  Xirui Jing; Qiuyue Ding; Qinxue Wu; Weijie Su; Keda Yu; Yanlin Su; Bing Ye; Qing Gao; Tingfang Sun; Xiaodong Guo
Journal:  Biomater Transl       Date:  2021-09-28

4.  A lean bioabsorbable magnesium-zinc-calcium alloy ZX00 used for operative treatment of medial malleolus fractures: early clinical results of a prospective non-randomized first in man study.

Authors:  Patrick Holweg; Valentin Herber; Martin Ornig; Gloria Hohenberger; Nicolas Donohue; Paul Puchwein; Andreas Leithner; Franz Seibert
Journal:  Bone Joint Res       Date:  2020-08-19       Impact factor: 5.853

5.  Influences of Extrusion and Silver Content on the Degradation of Mg-Ag Alloys In Vitro and In Vivo.

Authors:  Guanqi Liu; Jianmin Han; Xiaodong Yu; Shenpo Yuan; Zhihua Nie; Tiancheng Qiu; Ziyu Yan; Chengwen Tan; Chuanbin Guo
Journal:  Bioinorg Chem Appl       Date:  2022-04-23       Impact factor: 4.724

6.  Gas formation and biological effects of biodegradable magnesium in a preclinical and clinical observation.

Authors:  Yu-Kyoung Kim; Kwang-Bok Lee; Seo-Young Kim; Ken Bode; Yong-Seok Jang; Tae-Young Kwon; Moo Heon Jeon; Min-Ho Lee
Journal:  Sci Technol Adv Mater       Date:  2018-04-09       Impact factor: 8.090

7.  Proteome analysis of human mesenchymal stem cells undergoing chondrogenesis when exposed to the products of various magnesium-based materials degradation.

Authors:  Adela Helvia Martínez Sánchez; Maryam Omidi; Marcus Wurlitzer; Marceline Manka Fuh; Frank Feyerabend; Hartmut Schlüter; Regine Willumeit-Römer; Bérengère J C Luthringer
Journal:  Bioact Mater       Date:  2019-04-24

Review 8.  Resorbable implants in pediatric fracture treatment.

Authors:  Nicole Gabriele Grün; Patrick Lukas Holweg; Nicholas Donohue; Thomas Klestil; Annelie-Martina Weinberg
Journal:  Innov Surg Sci       Date:  2018-05-29

Review 9.  Biodegradable Magnesium-Based Implants in Orthopedics-A General Review and Perspectives.

Authors:  Jia-Li Wang; Jian-Kun Xu; Chelsea Hopkins; Dick Ho-Kiu Chow; Ling Qin
Journal:  Adv Sci (Weinh)       Date:  2020-02-28       Impact factor: 16.806

10.  Biocompatibility evaluation of antibacterial Ti-Ag alloys with nanotubular coatings.

Authors:  Xingwang Liu; Chen Chen; Hangzhou Zhang; Ang Tian; Junhua You; Lin Wu; Zeming Lei; Xi Li; Xizhuang Bai; Shiyi Chen
Journal:  Int J Nanomedicine       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.